VWD References


Berntorp, E., and T. Abshire. 2006. “The von Willebrand Disease Prophylaxis Network: Exploring a Treatment Concept.” Journal of Thrombosis & Haemostasis 4 (11): 2511–12. doi:10.1111/j.1538-7836.2006.02179.x.

Castaman, Giancarlo. 2013. “Changes of von Willebrand Factor during Pregnancy in Women with and without von Willebrand Disease.” Mediterranean Journal of Hematology and Infectious Diseases 5 (1). doi:10.4084/MJHID.2013.052.

James, Paula D., and Anne C. Goodeve. 2011. “Von Willebrand Disease.” Genetics in Medicine 13 (5): 365–76. doi:10.1097/GIM.0b013e3182035931.

James, P.D., and D. Lillicrap. 2013. “The Molecular Characterization of von Willebrand Disease: Good in Parts.” British Journal of Haematology 161 (2): 166–76. doi:10.1111/bjh.12249.

Lassila, R., and O. Lindberg. 2013. “Erik von Willebrand.” Haemophilia 19 (5): 643–47. doi:10.1111/hae.12243.

Lillicrap, D. 2009. “Genotype/Phenotype Association in von Willebrand Disease: Is the Glass Half Full or Empty?” Journal of Thrombosis and Haemostasis 7 (July): 65–70. doi:10.1111/j.1538-7836.2009.03367.x.

Lillicrap, David. 2013a. “Translational Medicine Advances in von Willebrand Disease.” Journal of Thrombosis and Haemostasis : JTH 11 (0 1): 75–83. doi:10.1111/jth.12257.

Lillicrap, David. 2013b. “Von Willebrand Disease: Advances in Pathogenetic Understanding, Diagnosis, and Therapy.” Blood 122 (23): 3735–40. doi:10.1182/blood-2013-06-498303.

Mancuso, D. J., E. A. Tuley, L. A. Westfield, N. K. Worrall, B. B. Shelton-Inloes, J. M. Sorace, Y. G. Alevy, and J. E. Sadler. 1989. “Structure of the Gene for Human von Willebrand Factor.” Journal of Biological Chemistry 264 (33): 19514–27.

Michaux, Grégoire, Kate B. Abbitt, Lucy M. Collinson, Sandra L. Haberichter, Keith E. Norman, and Daniel F. Cutler. 2006. “The Physiological Function of von Willebrand’s Factor Depends on Its Tubular Storage in Endothelial Weibel-Palade Bodies.” Developmental Cell 10 (2): 223–32. doi:10.1016/j.devcel.2005.12.012.

Neff, Anne T. 2015. “Current Controversies in the Diagnosis and Management of von Willebrand Disease.” Therapeutic Advances in Hematology 6 (4): 209–16. doi:10.1177/2040620715587879.

Ng, Christopher, David G. Motto, and Jorge Di Paola. 2015. “Diagnostic Approach to von Willebrand Disease.” Blood 125 (13): 2029–37. doi:10.1182/blood-2014-08-528398.

O’Brien, Lee A., Paula D. James, Maha Othman, Ergul Berber, Cherie Cameron, Colleen R. P. Notley, Carol A. Hegadorn, et al. 2003. “Founder von Willebrand Factor Haplotype Associated with Type 1 von Willebrand Disease.” Blood 102 (2): 549–57. doi:10.1182/blood-2002-12-3693.

Owens, Colleen. 2007. “Erik Adolf von Willebrand: 1870-1949.” Healio HemOnc Today. July. http://www.healio.com/hematology-oncology/news/print/hemonc-today/%7B6ab2a444-5eee-4a94-aabc-fb7621e133fd%7D/erik-adolf-von-willebrand-1870-1949.

Pruss, Cynthia M., Mia Golder, Andrea Bryant, Carol A. Hegadorn, Erin Burnett, Kimberly Laverty, Kate Sponagle, et al. 2011. “Pathologic Mechanisms of Type 1 VWD Mutations R1205H and Y1584C through in Vitro and in Vivo Mouse Models.” Blood 117 (16): 4358–66. doi:10.1182/blood-2010-08-303727.

Rydz, Natalia, Julie Grabell, David Lillicrap, and Paula D. James. 2015. “Changes in von Willebrand Factor Level and von Willebrand Activity with Age in Type 1 von Willebrand Disease.” Haemophilia : The Official Journal of the World Federation of Hemophilia 21 (5): 636–41. doi:10.1111/hae.12664.

Sadler, J. E., U. Budde, J. C. J. Eikenboom, E. J. Favaloro, F. G. H. Hill, L. Holmberg, J. Ingerslev, et al. 2006. “Update on the Pathophysiology and Classification of von Willebrand Disease: A Report of the Subcommittee on von Willebrand Factor.” Journal of Thrombosis and Haemostasis 4 (10): 2103–14. doi:10.1111/j.1538-7836.2006.02146.x.

Sadler, J. Evan. 2003. “Von Willebrand Disease Type 1: A Diagnosis in Search of a Disease.” Blood 101 (6): 2089–93. doi:10.1182/blood-2002-09-2892.

Smeets, Michel W. J., Ruben Bierings, Henriet Meems, Frederik P. J. Mul, Dirk Geerts, Alexander P. J. Vlaar, Jan Voorberg, and Peter L. Hordijk. 2017. “Platelet-Independent Adhesion of Calcium-Loaded Erythrocytes to von Willebrand Factor.” PLOS ONE 12 (3): e0173077. doi:10.1371/journal.pone.0173077.

Starke, Richard D., Koralia E. Paschalaki, Clare E. F. Dyer, Kimberly J. Harrison-Lavoie, Jacqueline A. Cutler, Thomas A. J. McKinnon, Carolyn M. Millar, Daniel F. Cutler, Mike A. Laffan, and Anna M. Randi. 2013. “Cellular and Molecular Basis of von Willebrand Disease: Studies on Blood Outgrowth Endothelial Cells.” Blood 121 (14): 2773–84. doi:10.1182/blood-2012-06-435727.

Veyradier, Agnès, Pierre Boisseau, Edith Fressinaud, Claudine Caron, Catherine Ternisien, Mathilde Giraud, Christophe Zawadzki, et al. 2016. “A Laboratory Phenotype/Genotype Correlation of 1167 French Patients From 670 Families With von Willebrand Disease.” Medicine 95 (11). doi:10.1097/MD.0000000000003038.

Xie, Lijuan, Colin N. Chesterman, and Philip J. Hogg. 2001. “Control of Von Willebrand Factor Multimer Size by Thrombospondin-1.” The Journal of Experimental Medicine 193 (12): 1341–50.

Yadegari, Hamideh, Arijit Biswas, Mohammad Suhail Akhter, Julia Driesen, Vytautas Ivaskevicius, Natascha Marquardt, and Johannes Oldenburg. 2016. “Intron Retention Resulting from a Silent Mutation in the VWF Gene That Structurally Influences the 5′ Splice Site.” Blood 128 (17): 2144–52. doi:10.1182/blood-2016-02-699686.


Comments are closed.